| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 220 | 44.177 | 60.353 | 20.184 |
| Total Income - EUR | - | - | - | - | - | - | 220 | 44.169 | 60.486 | 20.277 |
| Total Expenses - EUR | - | - | - | - | - | - | 1.764 | 28.579 | 57.760 | 25.786 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -1.544 | 15.590 | 2.726 | -5.509 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -1.551 | 14.477 | 1.106 | -5.509 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bioexpertmedica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 2.060 | 12.785 | 9.534 | 6.349 |
| Current Assets | - | - | - | - | - | - | 176 | 873 | 4.502 | 4.180 |
| Inventories | - | - | - | - | - | - | 0 | 743 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 72 | 443 | 440 |
| Cash | - | - | - | - | - | - | 176 | 59 | 4.059 | 3.740 |
| Shareholders Funds | - | - | - | - | - | - | -1.510 | 12.962 | 14.029 | 8.442 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 3.746 | 696 | 6 | 2.088 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4727 - 4727" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Bioexpertmedica S.r.l.